Wolverine Trading, LLC Arrowhead Pharmaceuticals, Inc. Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

22 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$21.87 - $28.24 $185,895 - $240,040	-8,500 Reduced 52.47%	7,700 $200,000
Q1 2024 May 15, 2024	SELL	$27.21 - $39.48 $413,592 - $600,096	-15,200 Reduced 48.41%	16,200 $463,000
Q4 2023 Feb 14, 2024	BUY	$21.2 - $31.03 $498,200 - $729,205	23,500 Added 297.47%	31,400 $960,000
Q3 2023 Nov 15, 2023	SELL	$26.2 - $36.08 $75,980 - $104,632	-2,900 Reduced 26.85%	7,900 $212,000
Q2 2023 Aug 23, 2023	SELL	$25.16 - $41.38 $88,060 - $144,830	-3,500 Reduced 24.48%	10,800 $385,000
Q1 2023 May 15, 2023	SELL	$23.68 - $38.51 $390,720 - $635,415	-16,500 Reduced 53.57%	14,300 $349,000
Q4 2022 Feb 14, 2023	BUY	$28.0 - $40.56 $249,200 - $360,984	8,900 Added 40.64%	30,800 $1.25 Million
Q3 2022 Nov 14, 2022	BUY	$29.63 - $48.31 $65,186 - $106,282	2,200 Added 11.17%	21,900 $729,000
Q2 2022 Aug 15, 2022	SELL	$27.79 - $50.61 $150,066 - $273,294	-5,400 Reduced 21.51%	19,700 $681,000
Q1 2022 May 16, 2022	SELL	$39.62 - $69.97 $1.7 Million - $2.99 Million	-42,800 Reduced 63.03%	25,100 $1.14 Million
Q4 2021 Feb 14, 2022	BUY	$58.09 - $82.51 $3.94 Million - $5.6 Million	67,900 New	67,900 $4.57 Million
Q2 2020 Aug 13, 2020	SELL	$26.12 - $43.27 $2.9 Million - $4.81 Million	-111,200 Closed	0 $0
Q1 2020 May 11, 2020	SELL	$20.56 - $63.12 $1.56 Million - $4.79 Million	-75,900 Reduced 40.57%	111,200 $3.22 Million
Q4 2019 Feb 12, 2020	BUY	$28.14 - $73.01 $523,404 - $1.36 Million	18,600 Added 11.04%	187,100 $12 Million
Q3 2019 Nov 14, 2019	SELL	$26.26 - $34.86 $86,658 - $115,038	-3,300 Reduced 1.92%	168,500 $4.54 Million
Q2 2019 Aug 20, 2019	BUY	$17.43 - $28.82 $1.81 Million - $3 Million	104,000 Added 153.39%	171,800 $4.55 Million
Q1 2019 May 15, 2019	BUY	$12.05 - $20.18 $103,630 - $173,548	8,600 Added 14.53%	67,800 $1.24 Million
Q4 2018 Feb 14, 2019	SELL	$10.74 - $19.7 $674,472 - $1.24 Million	-62,800 Reduced 51.48%	59,200 $707,000
Q3 2018 Nov 14, 2018	BUY	$14.0 - $20.3 $981,400 - $1.42 Million	70,100 Added 135.07%	122,000 $2.34 Million
Q1 2018 May 15, 2018	BUY	$3.72 - $7.64 $91,140 - $187,180	24,500 Added 89.42%	51,900 $374,000
Q4 2017 Feb 14, 2018	SELL	$3.14 - $4.5 $92,944 - $133,200	-29,600 Reduced 51.93%	27,400 $101,000
Q3 2017 Nov 15, 2017	BUY	$1.69 - $4.33 $96,330 - $246,810	57,000	57,000 $247,000

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.8M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.08B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account